United States · FDA National Drug Code directory
Risedronate Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-107_56e83e0f-83f7-4039-a9b2-0d5ae251e2b1
- Product NDC
- 33342-107
- Form
- TABLET, FILM COATED
- Composition / generic term
- Risedronate Sodium
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20151209
- Source listing expiry
- 20271231
Source-listed ingredients
- RISEDRONATE SODIUM — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (33342-107-06) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 33342-107-06
- 30 TABLET, FILM COATED in 1 CONTAINER (33342-107-07) · 33342-107-07
- 2000 TABLET, FILM COATED in 1 CONTAINER (33342-107-49) · 33342-107-49
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →